Literature DB >> 19481619

The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models.

Kristy M Wood1, Gregory M Stone, Nicholas A Peppas.   

Abstract

A novel class of pH-sensitive complexation hydrogels composed of methacrylic acid and functionalized poly(ethylene glycol) (PEG) tethers, referred to as P(MAA-g-EG) WGA, was investigated as an oral protein delivery system. The PEG tethers were functionalized with wheatgerm agglutinin (WGA), a lectin that can bind to carbohydrates in the intestinal mucosa, to improve residence time of the carrier and absorption of the drug at the delivery site. The ability of P(MAA-g-EG) WGA to improve insulin absorption was observed in two different intestinal epithelial models. In Caco-2 cells P(MAA-g-EG) WGA improved insulin permeability 9-fold as compared with an insulin only solution, which was similar to the improvement by P(MAA-g-EG). P(MAA-g-EG) and P(MAA-g-EG) WGA were also evaluated in a mucus-secreting culture that contained Caco-2 and HT29-MTX cells. Insulin permeability was increased 5-fold in the presence of P(MAA-g-EG) and P(MAA-g-EG) WGA. Overall, it is clear that P(MAA-g-EG) WGA enhances insulin absorption and holds great promise as an oral insulin delivery system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481619      PMCID: PMC3042261          DOI: 10.1016/j.actbio.2009.05.032

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  30 in total

1.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 2.  Barrier function of epithelia.

Authors:  D W Powell
Journal:  Am J Physiol       Date:  1981-10

3.  Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells.

Authors:  T Lesuffleur; A Barbat; E Dussaulx; A Zweibaum
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

4.  Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.

Authors:  Hideki Ichikawa; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2003-11-01       Impact factor: 4.396

5.  Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures.

Authors:  Aaron C Foss; Nicholas A Peppas
Journal:  Eur J Pharm Biopharm       Date:  2004-05       Impact factor: 5.571

6.  pH-Sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco-2 cell model.

Authors:  Madeline Torres-Lugo; Marcos García; Rae Record; Nicholas A Peppas
Journal:  Biotechnol Prog       Date:  2002 May-Jun

7.  Development of acrylic-based copolymers for oral insulin delivery.

Authors:  Aaron C Foss; Takahiro Goto; Mariko Morishita; Nicholas A Peppas
Journal:  Eur J Pharm Biopharm       Date:  2004-03       Impact factor: 5.571

8.  Quantification of ligand surface concentration of bulk-modified biomimetic hydrogels.

Authors:  Esfandiar Behravesh; Vassilios I Sikavitsas; Antonios G Mikos
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

9.  Cellular evaluation of insulin transmucosal delivery.

Authors:  Jennifer E López; Nicholas A Peppas
Journal:  J Biomater Sci Polym Ed       Date:  2004       Impact factor: 3.517

10.  Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?

Authors:  Isabel Behrens; Thomas Kissel
Journal:  Eur J Pharm Sci       Date:  2003-08       Impact factor: 4.384

View more
  15 in total

Review 1.  Microfabrication technologies for oral drug delivery.

Authors:  Shilpa Sant; Sarah L Tao; Omar Z Fisher; Qiaobing Xu; Nicholas A Peppas; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2011-12-04       Impact factor: 15.470

Review 2.  Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems.

Authors:  Mary Caldorera-Moore; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2009-09-14       Impact factor: 15.470

3.  Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.

Authors:  Matilde Durán-Lobato; Brenda Carrillo-Conde; Yasmine Khairandish; Nicholas A Peppas
Journal:  Biomacromolecules       Date:  2014-07-02       Impact factor: 6.988

Review 4.  Recent advances in hemophilia B therapy.

Authors:  Sarena D Horava; Nicholas A Peppas
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

5.  Hybrid responsive hydrogel carriers for oral delivery of low molecular weight therapeutic agents.

Authors:  M Caldorera-Moore; K Maass; R Hegab; G Fletcher; N Peppas
Journal:  J Drug Deliv Sci Technol       Date:  2015-12-01       Impact factor: 3.981

6.  Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics.

Authors:  William B Liechty; Mary Caldorera-Moore; Margaret A Phillips; Cody Schoener; Nicholas A Peppas
Journal:  J Control Release       Date:  2011-06-14       Impact factor: 9.776

7.  Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly(methacrylic acid-grafted-ethylene glycol) nanoparticles.

Authors:  Mary Caldorera-Moore; Julia E Vela Ramirez; Nicholas A Peppas
Journal:  J Drug Target       Date:  2019-03-01       Impact factor: 5.121

Review 8.  Planar bioadhesive microdevices: a new technology for oral drug delivery.

Authors:  Cade B Fox; Hariharasudhan D Chirra; Tejal A Desai
Journal:  Curr Pharm Biotechnol       Date:  2014       Impact factor: 2.837

9.  Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IX.

Authors:  Sarena D Horava; Nicholas A Peppas
Journal:  Ann Biomed Eng       Date:  2016-02-16       Impact factor: 3.934

10.  An inulin and doxorubicin conjugate for improving cancer therapy.

Authors:  C A Schoener; B Carillo-Conde; H N Hutson; N A Peppas
Journal:  J Drug Deliv Sci Technol       Date:  2013       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.